J Cancer 2018; 9(1):198-204. doi:10.7150/jca.22145

Research Paper

KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck

Donghai Huang1,2, Yuanzheng Qiu1,2, Guo Li1,2, Chao Liu1,2, Li She1,2, Diekuo Zhang1,2, Xiyu Chen1,2, Gangcai Zhu1,2, Xin Zhang1,2, Yongquan Tian1,2, Yong Liu1,2✉

1. Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China;
2. Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Xiangya Road 87, Changsha 410008, Hunan, China.

Abstract

Purpose: Lysine demethylase (KDM) 5B, as a member of the histone lysine demethylase family, is overexpressed and functions abnormally in various human cancers. However, its expression in the squamous cell carcinoma of the head and neck (SCCHN) remains unclear.

Methods: KDM5B expression was analyzed by immunohistochemistry and correlated with clinicopathological parameters in 103 archival SCCHN tissue samples and 24 adjacent noncancerous epithelial tissues.

Results: We found that KDM5B expression was higher in SCCHN than that in adjacent noncancerous tissues. This was closely associated with lymph node metastasis and tumor recurrence. In addition, Kaplan-Meier analysis revealed that patients with high KDM5B expression had shorter disease-free and overall survival times than those with low KDM5B expression. Importantly, both univariate and multivariate analysis demonstrated that KDM5B level was an independent prognostic factor in SCCHN patients.

Conclusions: These results indicate that KDM5B is a valuable biomarker that can be used to predict SCCHN patient outcome.

Keywords: Head and neck cancer, Squamous cell carcinoma, KDM5B, Metastasis, Prognosis.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Huang D, Qiu Y, Li G, Liu C, She L, Zhang D, Chen X, Zhu G, Zhang X, Tian Y, Liu Y. KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck. J Cancer 2018; 9(1):198-204. doi:10.7150/jca.22145. Available from http://www.jcancer.org/v09p0198.htm